These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38422787)

  • 1. In vivo quasi-elastic light scattering detects molecular changes in the lenses of adolescents with Down syndrome.
    Sarangi S; Minaeva O; Ledoux DM; Parsons DS; Moncaster JA; Black CA; Hollander J; Tripodis Y; Clark JI; Hunter DG; Goldstein LE
    Exp Eye Res; 2024 Apr; 241():109818. PubMed ID: 38422787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome.
    Moncaster JA; Pineda R; Moir RD; Lu S; Burton MA; Ghosh JG; Ericsson M; Soscia SJ; Mocofanescu A; Folkerth RD; Robb RM; Kuszak JR; Clark JI; Tanzi RE; Hunter DG; Goldstein LE
    PLoS One; 2010 May; 5(5):e10659. PubMed ID: 20502642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease amyloid-β pathology in the lens of the eye.
    Moncaster JA; Moir RD; Burton MA; Chadwick O; Minaeva O; Alvarez VE; Ericsson M; Clark JI; McKee AC; Tanzi RE; Goldstein LE
    Exp Eye Res; 2022 Aug; 221():108974. PubMed ID: 35202705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vivo anterior segment OCT imaging provides unique insight into cerulean blue-dot opacities and cataracts in Down syndrome.
    Little JA; Mahil AS; Richardson P; Woodhouse JM; Vinuela-Navarro V; Saunders KJ
    Sci Rep; 2020 Jun; 10(1):10031. PubMed ID: 32572106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer's disease progression in Down syndrome.
    Zammit MD; Tudorascu DL; Laymon CM; Hartley SL; Zaman SH; Ances BM; Johnson SC; Stone CK; Mathis CA; Klunk WE; Cohen AD; Handen BL; Christian BT
    Neuroimage; 2021 Mar; 228():117728. PubMed ID: 33421595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease.
    Goldstein LE; Muffat JA; Cherny RA; Moir RD; Ericsson MH; Huang X; Mavros C; Coccia JA; Faget KY; Fitch KA; Masters CL; Tanzi RE; Chylack LT; Bush AI
    Lancet; 2003 Apr; 361(9365):1258-65. PubMed ID: 12699953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains.
    Gkanatsiou E; Sahlin C; Portelius E; Johannesson M; Söderberg L; Fälting J; Basun H; Möller C; Odergren T; Zetterberg H; Blennow K; Lannfelt L; Brinkmalm G
    Neurosci Lett; 2021 May; 754():135894. PubMed ID: 33848613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promise and challenge: the lens model as a biomarker for early diagnosis of Alzheimer's disease.
    Tian T; Zhang B; Jia Y; Li Z
    Dis Markers; 2014; 2014():826503. PubMed ID: 24688166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
    Asai M; Kawakubo T; Mori R; Iwata N
    Yakugaku Zasshi; 2017; 137(7):801-805. PubMed ID: 28674290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microvascular changes in Down syndrome with Alzheimer's-type pathology: Insights into a potential vascular mechanism for Down syndrome and Alzheimer's disease.
    Drachman DA; Smith TW; Alkamachi B; Kane K
    Alzheimers Dement; 2017 Dec; 13(12):1389-1396. PubMed ID: 28627379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
    Fortea J; Vilaplana E; Carmona-Iragui M; Benejam B; Videla L; Barroeta I; Fernández S; Altuna M; Pegueroles J; Montal V; Valldeneu S; Giménez S; González-Ortiz S; Muñoz L; Estellés T; Illán-Gala I; Belbin O; Camacho V; Wilson LR; Annus T; Osorio RS; Videla S; Lehmann S; Holland AJ; Alcolea D; Clarimón J; Zaman SH; Blesa R; Lleó A
    Lancet; 2020 Jun; 395(10242):1988-1997. PubMed ID: 32593336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo Quasi-Elastic Light Scattering Eye Scanner Detects Molecular Aging in Humans.
    Minaeva O; Sarangi S; Ledoux DM; Moncaster JA; Parsons DS; Washicosky KJ; Black CA; Weng FJ; Ericsson M; Moir RD; Tripodis Y; Clark JI; Tanzi RE; Hunter DG; Goldstein LE
    J Gerontol A Biol Sci Med Sci; 2020 Sep; 75(9):e53-e62. PubMed ID: 32515825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of beta-amyloid in cortical cataracts of donors with and without Alzheimer's disease.
    Michael R; Rosandić J; Montenegro GA; Lobato E; Tresserra F; Barraquer RI; Vrensen GF
    Exp Eye Res; 2013 Jan; 106():5-13. PubMed ID: 23142516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The amyloid plaque proteome in early onset Alzheimer's disease and Down syndrome.
    Drummond E; Kavanagh T; Pires G; Marta-Ariza M; Kanshin E; Nayak S; Faustin A; Berdah V; Ueberheide B; Wisniewski T
    Acta Neuropathol Commun; 2022 Apr; 10(1):53. PubMed ID: 35418158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aβ and tau prions feature in the neuropathogenesis of Down syndrome.
    Condello C; Maxwell AM; Castillo E; Aoyagi A; Graff C; Ingelsson M; Lannfelt L; Bird TD; Keene CD; Seeley WW; Perl DP; Head E; Prusiner SB
    Proc Natl Acad Sci U S A; 2022 Nov; 119(46):e2212954119. PubMed ID: 36343257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers.
    Janelidze S; Christian BT; Price J; Laymon C; Schupf N; Klunk WE; Lott I; Silverman W; Rosas HD; Zaman S; Mapstone M; Lai F; Ances BM; Handen BL; Hansson O
    JAMA Neurol; 2022 Aug; 79(8):797-807. PubMed ID: 35789365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring Alzheimer molecular pathology in Down's syndrome cerebrospinal fluid.
    Portelius E; Soininen H; Andreasson U; Zetterberg H; Persson R; Karlsson G; Blennow K; Herukka SK; Mattsson N
    Neurodegener Dis; 2014; 14(2):98-106. PubMed ID: 24992945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation between Alzheimer disease and cataract].
    Liu SS; Zhu SQ
    Zhonghua Yan Ke Za Zhi; 2017 Apr; 53(4):314-316. PubMed ID: 28412806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of plasma biomarkers in Down syndrome: the relative levels of Aβ42 decrease with age, whereas NT1 tau and NfL increase.
    Mengel D; Liu W; Glynn RJ; Selkoe DJ; Strydom A; Lai F; Rosas HD; Torres A; Patsiogiannis V; Skotko B; Walsh DM
    Alzheimers Res Ther; 2020 Mar; 12(1):27. PubMed ID: 32192521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbleeds and Cerebral Amyloid Angiopathy in the Brains of People with Down Syndrome with Alzheimer's Disease.
    Helman AM; Siever M; McCarty KL; Lott IT; Doran E; Abner EL; Schmitt FA; Head E
    J Alzheimers Dis; 2019; 67(1):103-112. PubMed ID: 30452414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.